US Pharma MarketingPrediction markets have permeated the worlds of sports, politics, and reality television shows. Now, the biopharma industry could be next. research FDA virology Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Billing Log Out A decade of reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT Events Search Log In Try STAT+ My Account Home Pharma Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals Company touts…
Prediction markets have permeated the worlds of sports, politics, and reality television shows. Now, the biopharma industry could be next.
On Thursday, Kalshi, one of the world’s largest prediction market exchanges, said it will start taking bets on clinical trials and regulatory approvals.
It’s starting with a small number of markets chosen in collaboration with its partner, AppliedXL, a tech company that monitors and predicts the outcomes of clinical trials.
Source: STAT News Pharma